Skip to content

Efiicacy of vitamin D on chronic lung disease

Efiicacy of vitamin D supplementation on pulmonary function tests of chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015012720828N1
Enrollment
23
Registered
2015-06-09
Start date
2011-01-31
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive airway diseases. Chronic obstructive pulmonary disease, unspecified

Interventions

3000000-600000 IU of vitamin D as loading dose and 50000 IU weekly for three month.
Treatment - Drugs
3000000-600000 IU of vitamin D as loading dose and 50000 IU weekly for three month

Sponsors

Vice chancellery for Development, Research and Technology of of Iran University of medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 139 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients who were current or ex-smokers or were exposed to noxious inhalents; had a diagnosis of chronic obstructive pulmonary disease according to the gobal initiative for chronic obstructive lung Disease definition; had no history of chronic obstructive pulmonary disease exacerbation one year before study; no history of renal stone or renal failure or other diseases that interact with vitamin D metabolism or were not taking vitamin D or calcium supplements ; no continuse need to oxygen therapy or during exercise. Exclusion characteria: noncompliance; exacerbation of chronic obstructive pulmonary disese during study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Forced expiratory volume in one second. Timepoint: before intervention and three month later at the end of study. Method of measurement: percent of predicted.

Secondary

MeasureTime frame
Saturation of oxygen and six minutes walk test. Timepoint: before intervention and three months after intervention. Method of measurement: percent and meters.;Saturation of oxygen and six minutes walk test. Timepoint: before intervention and three month later at the end of the study. Method of measurement: percent and meter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam haddadzadeh Shoushtari

Ahvaz jundishapour university of medical sciences

haddadzadeh-m@ajums.ac.irm.haddadzadeh_sh@yahoo.com+98 61 3292 1839

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026